Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study

BACKGROUND: Systemic corticosteroids are often used to treat inflammatory bowel disease (IBD) flares during pregnancy as maintenance of disease remission is crucial to optimize pregnancy outcomes. However, there is little data regarding the effect of in utero exposure to corticosteroids on the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Jølving, Line Riis, Nielsen, Jan, Andersen, Mette Louise, Friedman, Sonia, Nørgård, Bente Mertz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091841/
https://www.ncbi.nlm.nih.gov/pubmed/37046314
http://dx.doi.org/10.1186/s12916-023-02817-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091841/
https://www.ncbi.nlm.nih.gov/pubmed/37046314
http://dx.doi.org/10.1186/s12916-023-02817-7

Ejemplares similares